Cureus, in collaboration with Targeted Medical Education (TME), is proud to introduce the first Genomic Revolution in Breast Cancer: Innovative Uses for Molecular Testing case report publishing competition.
The expansion of precision medicine driven by genomic and molecular testing is poised to significantly change the future of personalized cancer treatment. This competition seeks to highlight innovative use of genomic testing in breast cancer. In particular we are looking for case reports that explore the use of multipanel hereditary or genomic blood and/or tissue testing outside current accepted uses (i.e. use in patients who do not meet NCCN guidelines for testing, use in neoadjuvant therapy to guide and evaluate therapy outcomes, etc.).
Submissions shall document how genomic testing impacted patient treatment and/or follow-up, as well as discuss how the resulting strategies may have influenced the clinical outcome – either positive or negative.
Our goal is to share the results with the global oncology community and support clinicians in their ability to keep up with meaningful developments and bring genuine progress to their communities.
The winner of this competition will be determined by the peer review panel and general acclaim of the medical community using Cureus SIQ™ crowdsourcing technology. To encourage dissemination and cross-disciplinary awareness, all published materials will be indexed with PubMed Central and made accessible for open-access full article review. We encourage you to contribute!
Peer Review Panel
We’ve assembled a world-class peer review panel to review all submitted articles. Click on a reviewer name to learn more.
Article analysis and commentary performed by the peer review panel are strictly independent of the sponsor.
Karen BarbosaD.O. | Surgery
Breast Surgery, Alaska Breast Care Specialists
Paul BaronM.D., F.A.C.S. | Surgery
Roper St. Francis Breast Program, Roper St. Francis Hospital
Souzan El-EidM.D., F.A.C.S. | Surgery
Summerlin Hospital, CCCN
David EuhusM.D., F.A.C.S. | Surgery
Surgical Oncology, Johns Hopkins
Ian GradyM.D., F.A.C.S. | Surgery
Surgery, North Valley Breast Clinic
Cathy L. GrahamM.D., F.A.C.S. | Surgery
Surgery, Emory University School of Medicine, Emory St. Joseph's Medical Center
Alan HollingsworthM.D., F.A.C.S. | Surgery
Mercy Breast Center, Mercy Hospital - OKC
Dennis HolmesM.D., F.A.C.S. | Surgery
Margie Petersen Breast Center, St Johns Health Center
Kevin HughesM.D., F.A.C.S. | Surgery
Surgical Oncology, Mass General Hospital
Alison L. LaidleyM.D., F.A.C.S., F.R.C.S.C. | Surgery
Texas Breast Specialists, Texas Oncology, Medical City Dallas Hospital, Dallas, Texas
Laura LeeM.D. | Surgery
Comprehensive Breast Center, Desert Regional Hospital
Rakesh PatelM.D. | Radiation Oncology
Radiation Oncology, Good Samaritan Hospital
James PellicaneM.D., F.A.C.S. | Surgery
Surgery, Bon Secours Virginia Health System
Barry RosenM.D., F.A.C.S. | Surgery
Department of Surgery, Advocate Good Shepherd Hospital
Competition entries will appear below as they are published. Keep checking back for published articles!
Competition entry and article submission is entirely free. Eligible entrees are limited to the first 40 draft article submissions (only one entry per submitting author). All submitted work must be previously unpublished. Eligible entries are limited to case reports with a maximum of 2,500 words and 10 references.
All articles must be submitted and formatted via the template-driven, self-publishing Cureus platform. Authors are encouraged to include supporting animations and videos within their article submissions. For additional information on publishing with Cureus, please refer to our Author Guide.
Statement of Independence
- Cureus Publishing Competitions are intended to encourage medical discovery, document clinical experiences – be they positive, negative, or neutral - and foster broader educational outreach through open access publication that is free to both authors and readers.
- Article submissions must adhere to the described “call for articles” and are open to any and all related manufacturer or vendor technologies.
- As a firewall to ensure objective and credible science, article selection, editorial review, peer review and publication are strictly independent of sponsoring company.
- Winning articles are determined exclusively via peer review panel and community crowdsourced scoring. Neither sponsoring company, nor Cureus, can determine competition outcome.
A single $3,000 monetary prize will be awarded to the published article that receives the highest Cureus SIQ™ (Scholarly Impact Quotient™) score. In addition, the winning article authors will be invited to attend and present their case study at the 2017 annual TME scientific meeting (travel and related expenses inclusive).
Subsequent to a formal editorial and peer review, published articles undergo SIQ scoring - Cureus’ unique crowdsourced, secondary peer-review process. In addition to measuring engagement, SIQ allows the community-at-large to rate the quality of individual articles. Reviewers assign scores from 1 to 10 on criteria including clarity and rationale, clinical importance, study design and methods, data analysis, novelty of conclusions and quality of presentation.
Aggregated community SIQ scores allow clinicians and researchers to quickly assess article quality in a manner similar to that of Amazon® and Yelp® community reviews.
Eligible articles must receive a minimum of 5 scores. (A Cureus user can assign only one score per article.) As engagement and scoring is critical to winning, authors are highly encouraged to share their published articles via social media and email.
- Thursday, October 27, 2016 – Competition begins; articles may now be submitted
- Thursday, February 9, 2017 – Article submission deadline @ 5:00 pm PT
- Thursday, March 9, 2017 – Peer & editorial review of all eligible articles concludes @ 5:00 pm PT
- Thursday, April 13, 2017 – Competition crowdsourced review (SIQ) concludes @ 5:00 pm PT
- Thursday, April 20, 2017 – Winning article announced